Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: A report from the Children's Oncology Group

Michael J. Monument, Kirsten M. Johnson, Elizabeth McIlvaine, Lisa Abegglen, W. Scott Watkins, Lynn B. Jorde, Richard B. Womer, Natalie Beeler, Laura Monovich, Elizabeth R. Lawlor, Julia A. Bridge, Joshua D. Schiffman, Mark D. Krailo, R. Lor Randall, Stephen L. Lessnick

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: The genetics involved in Ewing sarcoma susceptibility and prognosis are poorly understood. EWS/FLI and related EWS/ETS chimeras upregulate numerous gene targets via promoter-based GGAA-microsatellite response elements. These microsatellites are highly polymorphic in humans, and preliminary evidence suggests EWS/FLI-mediated gene expression is highly dependent on the number of GGAA motifs within the microsatellite. Objectives: Here we sought to examine the polymorphic spectrum of a GGAA-microsatellite within the NR0B1 promoter (a critical EWS/FLI target) in primary Ewing sarcoma tumors, and characterize how this polymorphism influences gene expression and clinical outcomes. Results: A complex, bimodal pattern of EWS/FLI-mediated gene expression was observed across a wide range of GGAA motifs, with maximal expression observed in constructs containing 20-26 GGAA motifs. Relative to white European and African controls, the NR0B1 GGAA-microsatellite in tumor cells demonstrated a strong bias for haplotypes containing 21-25 GGAA motifs suggesting a relationship between microsatellite function and disease susceptibility. This selection bias was not a product of microsatellite instability in tumor samples, nor was there a correlation between NR0B1 GGAA-microsatellite polymorphisms and survival outcomes. Conclusions: These data suggest that GGAA-microsatellite polymorphisms observed in human populations modulate EWS/FLI-mediated gene expression and may influence disease susceptibility in Ewing sarcoma.

Original languageEnglish (US)
Article numbere104378
JournalPloS one
Volume9
Issue number8
DOIs
StatePublished - Aug 5 2014

Fingerprint

Ewing's Sarcoma
Oncology
sarcoma
Microsatellite Repeats
microsatellite repeats
Gene expression
Polymorphism
Gene Expression
Tumors
Disease Susceptibility
gene expression
genetic polymorphism
disease resistance
promoter regions
Microsatellite Instability
Selection Bias
Response Elements
neoplasms
chimerism
response elements

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

Monument, M. J., Johnson, K. M., McIlvaine, E., Abegglen, L., Scott Watkins, W., Jorde, L. B., ... Lessnick, S. L. (2014). Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: A report from the Children's Oncology Group. PloS one, 9(8), [e104378]. https://doi.org/10.1371/journal.pone.0104378

Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma : A report from the Children's Oncology Group. / Monument, Michael J.; Johnson, Kirsten M.; McIlvaine, Elizabeth; Abegglen, Lisa; Scott Watkins, W.; Jorde, Lynn B.; Womer, Richard B.; Beeler, Natalie; Monovich, Laura; Lawlor, Elizabeth R.; Bridge, Julia A.; Schiffman, Joshua D.; Krailo, Mark D.; Lor Randall, R.; Lessnick, Stephen L.

In: PloS one, Vol. 9, No. 8, e104378, 05.08.2014.

Research output: Contribution to journalArticle

Monument, MJ, Johnson, KM, McIlvaine, E, Abegglen, L, Scott Watkins, W, Jorde, LB, Womer, RB, Beeler, N, Monovich, L, Lawlor, ER, Bridge, JA, Schiffman, JD, Krailo, MD, Lor Randall, R & Lessnick, SL 2014, 'Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: A report from the Children's Oncology Group', PloS one, vol. 9, no. 8, e104378. https://doi.org/10.1371/journal.pone.0104378
Monument, Michael J. ; Johnson, Kirsten M. ; McIlvaine, Elizabeth ; Abegglen, Lisa ; Scott Watkins, W. ; Jorde, Lynn B. ; Womer, Richard B. ; Beeler, Natalie ; Monovich, Laura ; Lawlor, Elizabeth R. ; Bridge, Julia A. ; Schiffman, Joshua D. ; Krailo, Mark D. ; Lor Randall, R. ; Lessnick, Stephen L. / Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma : A report from the Children's Oncology Group. In: PloS one. 2014 ; Vol. 9, No. 8.
@article{d8ab3fd61368456193ff35084979ce5e,
title = "Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: A report from the Children's Oncology Group",
abstract = "Background: The genetics involved in Ewing sarcoma susceptibility and prognosis are poorly understood. EWS/FLI and related EWS/ETS chimeras upregulate numerous gene targets via promoter-based GGAA-microsatellite response elements. These microsatellites are highly polymorphic in humans, and preliminary evidence suggests EWS/FLI-mediated gene expression is highly dependent on the number of GGAA motifs within the microsatellite. Objectives: Here we sought to examine the polymorphic spectrum of a GGAA-microsatellite within the NR0B1 promoter (a critical EWS/FLI target) in primary Ewing sarcoma tumors, and characterize how this polymorphism influences gene expression and clinical outcomes. Results: A complex, bimodal pattern of EWS/FLI-mediated gene expression was observed across a wide range of GGAA motifs, with maximal expression observed in constructs containing 20-26 GGAA motifs. Relative to white European and African controls, the NR0B1 GGAA-microsatellite in tumor cells demonstrated a strong bias for haplotypes containing 21-25 GGAA motifs suggesting a relationship between microsatellite function and disease susceptibility. This selection bias was not a product of microsatellite instability in tumor samples, nor was there a correlation between NR0B1 GGAA-microsatellite polymorphisms and survival outcomes. Conclusions: These data suggest that GGAA-microsatellite polymorphisms observed in human populations modulate EWS/FLI-mediated gene expression and may influence disease susceptibility in Ewing sarcoma.",
author = "Monument, {Michael J.} and Johnson, {Kirsten M.} and Elizabeth McIlvaine and Lisa Abegglen and {Scott Watkins}, W. and Jorde, {Lynn B.} and Womer, {Richard B.} and Natalie Beeler and Laura Monovich and Lawlor, {Elizabeth R.} and Bridge, {Julia A.} and Schiffman, {Joshua D.} and Krailo, {Mark D.} and {Lor Randall}, R. and Lessnick, {Stephen L.}",
year = "2014",
month = "8",
day = "5",
doi = "10.1371/journal.pone.0104378",
language = "English (US)",
volume = "9",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma

T2 - A report from the Children's Oncology Group

AU - Monument, Michael J.

AU - Johnson, Kirsten M.

AU - McIlvaine, Elizabeth

AU - Abegglen, Lisa

AU - Scott Watkins, W.

AU - Jorde, Lynn B.

AU - Womer, Richard B.

AU - Beeler, Natalie

AU - Monovich, Laura

AU - Lawlor, Elizabeth R.

AU - Bridge, Julia A.

AU - Schiffman, Joshua D.

AU - Krailo, Mark D.

AU - Lor Randall, R.

AU - Lessnick, Stephen L.

PY - 2014/8/5

Y1 - 2014/8/5

N2 - Background: The genetics involved in Ewing sarcoma susceptibility and prognosis are poorly understood. EWS/FLI and related EWS/ETS chimeras upregulate numerous gene targets via promoter-based GGAA-microsatellite response elements. These microsatellites are highly polymorphic in humans, and preliminary evidence suggests EWS/FLI-mediated gene expression is highly dependent on the number of GGAA motifs within the microsatellite. Objectives: Here we sought to examine the polymorphic spectrum of a GGAA-microsatellite within the NR0B1 promoter (a critical EWS/FLI target) in primary Ewing sarcoma tumors, and characterize how this polymorphism influences gene expression and clinical outcomes. Results: A complex, bimodal pattern of EWS/FLI-mediated gene expression was observed across a wide range of GGAA motifs, with maximal expression observed in constructs containing 20-26 GGAA motifs. Relative to white European and African controls, the NR0B1 GGAA-microsatellite in tumor cells demonstrated a strong bias for haplotypes containing 21-25 GGAA motifs suggesting a relationship between microsatellite function and disease susceptibility. This selection bias was not a product of microsatellite instability in tumor samples, nor was there a correlation between NR0B1 GGAA-microsatellite polymorphisms and survival outcomes. Conclusions: These data suggest that GGAA-microsatellite polymorphisms observed in human populations modulate EWS/FLI-mediated gene expression and may influence disease susceptibility in Ewing sarcoma.

AB - Background: The genetics involved in Ewing sarcoma susceptibility and prognosis are poorly understood. EWS/FLI and related EWS/ETS chimeras upregulate numerous gene targets via promoter-based GGAA-microsatellite response elements. These microsatellites are highly polymorphic in humans, and preliminary evidence suggests EWS/FLI-mediated gene expression is highly dependent on the number of GGAA motifs within the microsatellite. Objectives: Here we sought to examine the polymorphic spectrum of a GGAA-microsatellite within the NR0B1 promoter (a critical EWS/FLI target) in primary Ewing sarcoma tumors, and characterize how this polymorphism influences gene expression and clinical outcomes. Results: A complex, bimodal pattern of EWS/FLI-mediated gene expression was observed across a wide range of GGAA motifs, with maximal expression observed in constructs containing 20-26 GGAA motifs. Relative to white European and African controls, the NR0B1 GGAA-microsatellite in tumor cells demonstrated a strong bias for haplotypes containing 21-25 GGAA motifs suggesting a relationship between microsatellite function and disease susceptibility. This selection bias was not a product of microsatellite instability in tumor samples, nor was there a correlation between NR0B1 GGAA-microsatellite polymorphisms and survival outcomes. Conclusions: These data suggest that GGAA-microsatellite polymorphisms observed in human populations modulate EWS/FLI-mediated gene expression and may influence disease susceptibility in Ewing sarcoma.

UR - http://www.scopus.com/inward/record.url?scp=84905643968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905643968&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0104378

DO - 10.1371/journal.pone.0104378

M3 - Article

C2 - 25093581

AN - SCOPUS:84905643968

VL - 9

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e104378

ER -